
By Rochelle Jenks: Before earnings, MAKO Surgical ( MAKO ) investors were just hoping for the company to meet ..... around but it wasn't quite yet a step forward. MAKO Surgical markets its Robotic-Arm Interactive Orthopedic
By PropThink: By Jake King MAKO Surgical 's ( MAKO ) first-quarter results did little to inspire our confidence ..... but for those who truly believe in the growth prospects, MAKO looks cheap relative to expectations. The main question that
MAKO Surgical Corp. ( MAKO ) Q1 2013 Earnings Call May 07 ..... ladies and gentlemen, and welcome to the MAKO Surgical Corp's 2013 First Quarter Results ..... seekingalpha.com/article/1412071- mako - surgical -corp-ceo-discusses-q1-2013
BMC , BWC , CA , CDXS , CHRW , CODI , DGI , DGIT , DIS , DVA , EA , ENPH , EXEL , GTEK, GA , GPOR , IAG , JAZZ , KGC , LYV , MAKO , MCEP , MCK , MDLZ , MITK , MRO , MYGN , NVTL , OAS , OCLR , OHI , ONXX , ORA , PRI , RBCN , SD , SGEN , SYMC , SYNC , TRIP
BMC , BWC , CA , CDXS , CHRW , CODI , DGI , DGIT , DIS , DVA , EA , ENPH , EXEL , GTEK, GA , GPOR , IAG , JAZZ , KGC , LYV , MAKO , MCEP , MCK , MDLZ , MITK , MRO , MYGN , NVTL , OAS , OCLR , OHI , ONXX , ORA , PRI , RBCN , SD , SGEN , SYMC , SYNC , TRIP
other extreme. That's exactly what occurred with MAKO Surgical ( MAKO ). After climbing to well above $40 in March 2012 ..... it's clear that there is ample skepticism about MAKO 's ability to reach profitability. With Q1 2013 earnings
By Nick Chiu: MAKO Surgical Corp. ( MAKO ) is a medical device company that markets its advanced robotic ..... osteoarthritic disease. Positive Trial Result for Robotic Arm System MAKO announced the first results from a ten-year, prospective
Mako Surgical ( MAKO +4% ) gains on an upgrade to Neutral by Mizuho Securities, raising it's price target from $12 to $14. Mizuho says that after being nearly halved over the past seven months due to growth concerns, consensus 2013 estimates
Early results from a study show that Mako Surgincal's ( MAKO ) robotic arm improves the accuracy of implant placements in knees and reduces pain. The trial is comparing Mako 's Restoris implant using the firm's robotic arm with
posting disappointing results for most of last year, MAKO Surgical ( MAKO ) confirmed its previous pre-earnings announcement ..... them. Q4 Is "Less Worse" During the fourth quarter, Mako sold 15 RIO systems versus 18 for the prior year quarter